Literature DB >> 13164381

Bovine antihaemophilic globulin in the treatment of haemophilia.

R G MACFARLANE, R BIGGS, E BIDWELL.   

Abstract

Entities:  

Keywords:  HEMOPHILIA/therapy; SERUM GLOBULIN

Mesh:

Substances:

Year:  1954        PMID: 13164381     DOI: 10.1016/s0140-6736(54)92208-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  The influence of drugs on bleeding.

Authors:  C WISHART
Journal:  Proc R Soc Med       Date:  1961-06

2.  RESISTANCE to corticotrophin.

Authors: 
Journal:  Br Med J       Date:  1957-05-04

3.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

4.  [Therapy of severe hemophilia A hemorrhages with freshly prepared plasma fraction I].

Authors:  M H HORDER
Journal:  Klin Wochenschr       Date:  1957-08-01

5.  Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.

Authors:  T R Griggs; H A Cooper; W P Webster; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

6.  Epsilon-aminocaproic acid therapy for dental extractions in haemophiliacs.

Authors:  M W Cooksey; C B Perry; A B Raper
Journal:  Br Med J       Date:  1966-12-31

7.  The history of haemophilia.

Authors:  G I Ingram
Journal:  J Clin Pathol       Date:  1976-06       Impact factor: 3.411

8.  [Hemophilia, deficiency condition or excess of antibodies?].

Authors:  E Hecht
Journal:  Klin Wochenschr       Date:  1966-07-15

9.  The interaction of bovine factor VIII with human platelets.

Authors:  E P Kirby; D C Mills
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.

Authors:  C D Forbes; R D Barr; G P McNicol; A S Douglas
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.